Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yucheng Fu

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Scientific Reports|February 27, 2025
Quantitative assessment of Ni<sup>+</sup> and He<sup>+</sup> ion irradiation damage in a tungsten heavy alloy under the simulated nuclear fusion environmentJames V Haag, Yucheng Fu, Weilin Jiang, et al.
Cell Death & Disease|February 9, 2021
Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcomaZhuochao Liu, Hongyi Wang, Chuanzhen Hu, et al.
Biochimica Et Biophysica Acta|September 6, 2016
Sex-determining region Y-box 9 acts downstream of NADPH oxidase to influence the effect of leptin on PPARγ1 expression in hepatic stellate cellsHaowen Qiao, Qing Cao, Yucheng Fu, et al.
Journal of Clinical Medicine|January 8, 2023
The Outcome of Discontinuing Tyrosine Kinase Inhibitors in Advanced Sarcoma Following a Favorable Tumor Response to Antiangiogenics TherapyZhusheng Zhang, Qiyuan Bao, Yucheng Fu, et al.
Hereditas|February 17, 2021
Development and analysis of long non-coding RNA-associated competing endogenous RNA network for osteosarcoma metastasisYucheng Fu, Qi Liu, Qiyuan Bao, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 3, 2022
DNA Base Pairing-Inspired Supramolecular Nanodrug Camouflaged by Cancer-Cell Membrane for Osteosarcoma TreatmentYucheng Fu, Guoyu He, Zhuochao Liu, et al.
Frontiers in Oncology|February 10, 2023
Progress and perspectives of perioperative immunotherapy in non-small cell lung cancerYurong Peng, Zhuo Li, Yucheng Fu, et al.
Frontiers in Oncology|April 17, 2023
Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancerYurong Peng, Zhuo Li, Yucheng Fu, et al.
Biomarker Research|March 8, 2022
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancerYue Pan, Yucheng Fu, Yue Zeng, et al.
Translational Oncology|May 14, 2024
CT-derived Radiomics Predicts the Efficacy of Tyrosine Kinase Inhibitors in Osteosarcoma Patients with Pulmonary MetastasisShanshui Zhou, Qi Liu, Yucheng Fu, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Scientific Reports|February 27, 2025
Quantitative assessment of Ni<sup>+</sup> and He<sup>+</sup> ion irradiation damage in a tungsten heavy alloy under the simulated nuclear fusion environmentJames V Haag, Yucheng Fu, Weilin Jiang, et al.
Cell Death & Disease|February 9, 2021
Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcomaZhuochao Liu, Hongyi Wang, Chuanzhen Hu, et al.
Biochimica Et Biophysica Acta|September 6, 2016
Sex-determining region Y-box 9 acts downstream of NADPH oxidase to influence the effect of leptin on PPARγ1 expression in hepatic stellate cellsHaowen Qiao, Qing Cao, Yucheng Fu, et al.
Journal of Clinical Medicine|January 8, 2023
The Outcome of Discontinuing Tyrosine Kinase Inhibitors in Advanced Sarcoma Following a Favorable Tumor Response to Antiangiogenics TherapyZhusheng Zhang, Qiyuan Bao, Yucheng Fu, et al.
Hereditas|February 17, 2021
Development and analysis of long non-coding RNA-associated competing endogenous RNA network for osteosarcoma metastasisYucheng Fu, Qi Liu, Qiyuan Bao, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 3, 2022
DNA Base Pairing-Inspired Supramolecular Nanodrug Camouflaged by Cancer-Cell Membrane for Osteosarcoma TreatmentYucheng Fu, Guoyu He, Zhuochao Liu, et al.
Frontiers in Oncology|February 10, 2023
Progress and perspectives of perioperative immunotherapy in non-small cell lung cancerYurong Peng, Zhuo Li, Yucheng Fu, et al.
Frontiers in Oncology|April 17, 2023
Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancerYurong Peng, Zhuo Li, Yucheng Fu, et al.
Biomarker Research|March 8, 2022
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancerYue Pan, Yucheng Fu, Yue Zeng, et al.
Translational Oncology|May 14, 2024
CT-derived Radiomics Predicts the Efficacy of Tyrosine Kinase Inhibitors in Osteosarcoma Patients with Pulmonary MetastasisShanshui Zhou, Qi Liu, Yucheng Fu, et al.
Pageof 4